Filing Flows

Filing Flows › Companies › Invo Fertility › Cash flow

Invo Fertility cash flow, quarter by quarter

Latest: Q2 2026 · from the cash-flow statements filed with the SEC

Free cash flow−$1.1M in Q2 2026 · −$4.8M over twelve months

Operating cash flow−$1.1M
Free cash flow−$1.1M
Cash / net income-1.2×
Cash conversion cycle-2103 days

Analysis

In Q2 2026, Invo Fertility generated −$1.1M of operating cash flow. That is $625K more than in Q2 2025 (−$1.7M).

Over the twelve months to Jun 30, 2026, operating cash flow was −$4.8M; the largest uses were operating cash flow ($4.8M), other investing ($2.9M), net borrowing (+) / repaid (−) ($233K); besides operations, cash came from other financing ($11.1M); the cash balance rose by $3.2M.

Operating cash flow was −$1.1M against net income of $889K — -1.2× profit, less cash than reported earnings, worth checking against working capital. The largest differences: depreciation & amortization +$146K, payables −$94K, employee-related liabilities +$74K.

Its cash conversion cycle was -2103 days (receivables 11 + inventory 360 − payables 2473): suppliers fund its working capital.

Free cash flow

Invo Fertility: free cash flow by quarterInvo Fertility: free cash flow by quarter−$641KQ3 2024−$696KQ4 2024−$3.6MQ1 2025−$1.7MQ2 2025−$1.8MQ3 2025$13KQ4 2025−$1.9MQ1 2026−$1.1MQ2 2026
Operating cash flow less capital spending.
Invo Fertility: operating cash flow against capital spendingInvo Fertility: operating cash flow against capital spendingOperating cash flowCapital spending−$641K$0Q3 2024−$617K$79KQ4 2024−$3.5M$15KQ1 2025−$1.7M$9KQ2 2025−$1.8M$8KQ3 2025$25K$12KQ4 2025−$1.9M$0Q1 2026−$1.1M$0Q2 2026
Latest (Q2 2026): Operating cash flow −$1.1M, Capital spending $0.

Capital allocation, year by year

Invo Fertility: where the cash came from (up) and went (down), by fiscal yearInvo Fertility: where the cash came from (up) and went (down), by fiscal yearOperating cash flowNet borrowingShares issuedAsset salesCapital spendingAcquisitionsFY2021: Operating cash flow −$6.0MFY2021: Net borrowing −$250KFY2021: Shares issued $7.4MFY2021: Capital spending −$416K$7.4MFY2021FY2022: Operating cash flow −$6.6MFY2022: Net borrowing $800KFY2022: Shares issued $290KFY2022: Capital spending −$11K$1.1MFY2022FY2023: Operating cash flow −$4.8MFY2023: Net borrowing $1.6MFY2023: Shares issued $5.7MFY2023: Capital spending −$445KFY2023: Acquisitions −$2.0M$7.3MFY2023FY2024: Operating cash flow −$3.0MFY2024: Net borrowing $410KFY2024: Shares issued $1.8MFY2024: Asset sales $76KFY2024: Capital spending −$184K$2.3MFY2024FY2025: Operating cash flow −$7.0MFY2025: Net borrowing −$1.2MFY2025: Shares issued $15.2MFY2025: Capital spending −$43K$15.2MFY2025
Over these 5 years operating cash flow totalled −$27.4M; the largest uses were operating cash flow ($27.4M) and acquisitions ($2.0M). Cash-flow statements as filed.

Cash runway and the debt wall

Cash & investments$3.7M
Debt$892K
Net cash$2.8M
Due within a year$1.1M
Cash runway9 months

Invo Fertility is burning cash: its operations consume cash, a free cash flow of −$4.8M a year at the current rate against $3.7M of cash and investments: a runway of about 9 months; $1.1M of debt also comes due within a year, which would need refinancing or new money before any new financing.

Where the cash came from and went

Invo Fertility: sources (+) and uses (−) of cash, Q2 2026Invo Fertility: sources (+) and uses (−) of cash, Q2 2026Cash drawn (+) / kept (−)$1.2MOperating cash flow−$1.1MNet borrowing (+) / repaid (−)−$68KOther investing−$2K
Invo Fertility: sources (+) and uses (−) of cash, TTM to Q2 2026Invo Fertility: sources (+) and uses (−) of cash, TTM to Q2 2026Other financing$11.1MOperating cash flow−$4.8MCash drawn (+) / kept (−)−$3.2MOther investing−$2.9MNet borrowing (+) / repaid (−)−$233KCapital spending−$39K

From profit to cash

Invo Fertility: net income to operating cash flow, Q2 2026Invo Fertility: net income to operating cash flow, Q2 2026Net income$889KDepreciation & amortization$146KReceivables−$35KInventory−$4KPayables−$94KEmployee-related liabilities$74KDeferred revenue$63KPrepaid and other assets$13KOperating cash flow−$1.1M
Non-cash charges are added back; money tied up in receivables or inventory is subtracted.
QuarterReceivable daysInventory daysPayable daysCash conversion cycle
Q2 2026113602473-2103
Q1 202610392932337-28398
Q2 2025106374104162-97779
Q1 2025818334-308
Q4 20241021261-230
Q3 20241723234-195

Every quarter

QuarterOperating cash flowCapital spendingNet borrowing (+) / repaid (−)Shares issuedCash drawn (+) / kept (−)Free cash flow
Q2 2026−$1.1M—−$68K—$1.2M−$1.1M
Q1 2026−$1.9M—−$117K$7.1M−$2.8M−$1.9M
Q4 2025$25K−$12K$30K$4.3M−$1.7M$13K
Q3 2025−$1.8M−$8K−$100K$1.6M$193K−$1.8M
Q2 2025−$1.7M−$9K——$291K−$1.7M
Q1 2025−$3.5M−$15K−$1.1M$8.7M−$99K−$3.6M
Q4 2024−$617K−$79K$494K—−$270K−$696K
Q3 2024−$641K—$32K$138K$471K−$641K

Invo Fertility: income statement and cash flow

Invo Fertility, Q2 2026: revenue $2.2M (+17% year over year), operating margin -59.3%. The chart follows the revenue to costs, profit and cash.

Invo Fertility: every quarter, Q/Q and Y/Y → Open in the app

Read automatically from the company’s XBRL cash-flow statements; quarterly figures for the fourth quarter are the year less the first three. Errors are possible. Not investment advice.